Iver Nordentoft

7.5k total citations
57 papers, 2.9k citations indexed

About

Iver Nordentoft is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Iver Nordentoft has authored 57 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Surgery, 25 papers in Molecular Biology and 24 papers in Cancer Research. Recurrent topics in Iver Nordentoft's work include Bladder and Urothelial Cancer Treatments (29 papers), Cancer Genomics and Diagnostics (19 papers) and Epigenetics and DNA Methylation (13 papers). Iver Nordentoft is often cited by papers focused on Bladder and Urothelial Cancer Treatments (29 papers), Cancer Genomics and Diagnostics (19 papers) and Epigenetics and DNA Methylation (13 papers). Iver Nordentoft collaborates with scholars based in Denmark, United States and Germany. Iver Nordentoft's co-authors include Lars Dyrskjøt, Torben F. Ørntoft, Søren Vang, Karin Birkenkamp‐Demtröder, Jørgen Bjerggaard Jensen, Philippe Lamy, Jakob Skou Pedersen, Mads Agerbæk, Emil Christensen and S. Høyer and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Iver Nordentoft

55 papers receiving 2.9k citations

Peers

Countries citing papers authored by Iver Nordentoft

Since Specialization

Citations

This map shows the geographic impact of Iver Nordentoft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iver Nordentoft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iver Nordentoft more than expected).

Fields of papers citing papers by Iver Nordentoft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iver Nordentoft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iver Nordentoft. The network helps show where Iver Nordentoft may publish in the future.

Co-authorship network of co-authors of Iver Nordentoft

This figure shows the co-authorship network connecting the top 25 collaborators of Iver Nordentoft. A scholar is included among the top collaborators of Iver Nordentoft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iver Nordentoft. Iver Nordentoft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Low T cell diversity associates with poor outcome in bladder cancer: A comprehensive longitudinal analysis of the T cell receptor repertoire	Cell Reports Medicine	Randi Istrup Juul, Iver Nordentoft et al.	1
2	1960O Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial	Annals of Oncology	Jørgen Bjerggaard Jensen, Karin Birkenkamp‐Demtröder et al.	15
3	Improved protocol for single-nucleus RNA-sequencing of frozen human bladder tumor biopsies	Nucleus	Iver Nordentoft, Sia V. Lindskrog et al.	2
4	Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer	Clinical Cancer Research	Emil Christensen, Iver Nordentoft et al.	36
5	Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up	Clinical Cancer Research	Sia V. Lindskrog, Karin Birkenkamp‐Demtröder et al.	26
6	Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer	European Urology	Trine Strandgaard, Iver Nordentoft et al.	21
7	Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non–muscle-invasive Bladder Cancer	European Urology	Trine Strandgaard, Sia V. Lindskrog et al.	39
8	SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer	European Urology Open Science	Philippe Lamy, Sia V. Lindskrog et al.	0
9	Mutational Analysis of Field Cancerization in Bladder Cancer	Bladder Cancer	Trine Strandgaard, Iver Nordentoft et al.	10
10	Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases	Modern Pathology	Gottfrid Sjödahl, Pontus Eriksson et al.	40
11	Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer	Clinical Cancer Research	Lone V. Schøler, Thomas Reinert et al.	230
12	Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer	Scientific Reports	Anna Katharina Seitz, Lise Lotte Christensen et al.	100
13	Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer	European Urology	Emil Christensen, Karin Birkenkamp‐Demtröder et al.	148
14	Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma	Cancer Research	Philippe Lamy, Iver Nordentoft et al.	68
15	Widespread DNA hypomethylation and differential gene expression in Turner syndrome	Scientific Reports	Christian Trolle, Morten Muhlig Nielsen et al.	93
16	Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma	Molecular Oncology	Mathilde Borg Houlberg Thomsen, Iver Nordentoft et al.	36
17	Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer	European Urology	Karin Birkenkamp‐Demtröder, Iver Nordentoft et al.	168
18	Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients	Leukemia	Marlene Dalgaard, Rachita Yadav et al.	14
19	Identification of expressed and conserved human noncoding RNAs	RNA	Morten Muhlig Nielsen, Disa Tehler et al.	41
20	Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer	BMC Cancer	Iver Nordentoft, Lars Dyrskjøt et al.	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact